Bioamber Inc

0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS

Case Summary
Company Name: Bioamber Inc
Stock Symbol : NYSE:BIOA
Class Period Start: 01/23/2017
Class Period End: 03/16/2017
Lead Plaintiff motion: 05/17/2017
Date Filed: 03/18/2017
Type of Case: Securities Class Action
Court: U.S. District Court for the Eastern District of New York
Summary:

Thieler Law Corp advises investors with losses exceeding $100,000 of the May 17, 2017 lead plaintiff deadline in a class action lawsuit filed against Bioamber Inc (NYSE:BIOA) (“Bioamber” or “the Company”). The suit is pending in the U.S. District Court for the Eastern District of New York and investors, who purchased Bioamber Inc securities between January 23, 2017 and March 16, 2017, have until May 17, 2017 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Bioamber Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that a large customer of the Company that was expected to purchase $2.8 million of succinic acid in the fourth quarter of 2016 postponed the order to 2017; and as a result, the Company's statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On March 16, 2017, BioAmber revealed its financial results for the 2016 fiscal year, revealing that the Company had failed to meet its predicted revenue forecast by $1.3 million. The Company’s President Fabrice Orecchioni blamed the disappointing results on “pricing pressures” and “a disruption from a large customer.”

Following this news, BioAmber stock declined, approximately 20%, to close at $2.55 on March 17, 2017.

If you were negatively impacted by your investment in Bioamber Inc securities between January 23, 2017 and March 16, 2017 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185

Transactions
Buy date (mm/dd/yyyy) Number of shares Price per share
Sell date (mm/dd/yyyy) Number of shares Price per share
Please wait...